
About this podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
211 episodes · Medicine
On The Pen GLP-1 News
About this podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 0.5% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Recent episodes
- Ozempic & Zepbound Are Changing America in Ways Nobody Expected7 Oct · 25 min
- They TRIPLED Wegovy Dose, Does it Beat Zepbound?1 Oct · 31 min
- Retatrutide in Court, Compound GLP-1 Under Fire22 Sept · 30 min
- 17% Weight Loss in 16 Weeks… Is This Better Than Retatrutide?15 Sept · 30 min
- GLP-1 for 6 Year Olds? Here’s What the Trial Actually Found8 Sept · 26 min
- We’re Solving Obesity. Now Who Pays for It?2 Sept · 25 min
- GLP-1 Coverage Is COLLAPSING in 202726 Aug · 35 min
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18 Aug · 45 min
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12 Aug · 31 min
- Eli Lilly Earnings Call Recap: Retatrutide News7 Aug · 1 h 00 min